Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer
- 11 October 2023
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 178, 89-95
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survivalEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignanciesGynecologic Oncology, 2013
- Prolonged postoperative venous thrombo-embolism prophylaxis is cost-effective in advanced ovarian cancer patientsGynecologic Oncology, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJournal of Thrombosis and Haemostasis, 2007
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced MalignancyJournal of Clinical Oncology, 2005
- Prognosis of Cancers Associated with Venous ThromboembolismNew England Journal of Medicine, 2000
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994